ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk to phase out key drug, insulin cos spot big biz opportunity
Novo Nordisk is set to discontinue some forms of its Mixtard insulin, including pen and cartridge versions, in India, coinciding with the anticipated launch of its weight-loss drug Wegovy. This move has prompted other major insulin manufacturers like Lupin
Announcement as on 23 April 2025

Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brand
Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global strategy. They will prioritize newer, patented therapies like Ozempic and Wegovy. The company plans to introduce these therapies in
Announcement as on 22 April 2025

Novo Nordisk readies to bring weight-loss drug Wegovy to India
Danish pharmaceutical company Novo Nordisk is set to launch its anti-diabetes and weight-loss drug Wegovy in India, aiming to outperform Eli Lilly's Mounjaro. Regulatory approval for Wegovy's cardiovascular benefits has been granted, pending final approval
Announcement as on 07 April 2025

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NYSE: NVO), famously the company behind Wegovy, and Viking Therapeutics (NASDAQ: VKTX), which is far along in
Announcement as on 11 February 2025

What's Happening With Novo Nordisk Stock?
Novo Nordisk ADR (NYSE: NVO) currently trades at per share, more than 40% below its peak level of over 5 seen in June of this year. In contrast, its closest peer, Eli Lilly stock (NYSE:LLY) is down 15% over this period. NVO stock was trading around
Announcement as on 26 December 2024

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 36.19
  • 12Day Average: 36.8
  • 20Day Average: 37.56
  • 50Day Average: 44.88
  • 100Day Average: 47.88
  • 150Day Average: 50.45
  • 200Day Average: 53.73

NVO Indicators & signals

Indicator MACD (12,26,9)

36.88, 38.99, -2.49
Indicator MACD is in negative zone

Indicator ADX (14)

23.29, 18.92, 30.41
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Wed Apr 2026 36.48 35.78 to 37.44 -0.73% 1.21 times
31 Tue Mar 2026 36.75 35.32 to 36.75 4.05% 1.2 times
30 Mon Mar 2026 35.32 35.06 to 35.65 -1.97% 0.86 times
27 Fri Mar 2026 36.03 35.89 to 37.20 -0.96% 0.74 times
26 Thu Mar 2026 36.38 35.51 to 37.44 0.14% 1.05 times
25 Wed Mar 2026 36.33 36.23 to 37.39 -1.52% 1.04 times
24 Tue Mar 2026 36.89 36.55 to 37.20 0.19% 1.02 times
23 Mon Mar 2026 36.82 36.48 to 37.21 0.77% 0.95 times
20 Fri Mar 2026 36.54 35.86 to 37.33 -1.43% 1.4 times
19 Thu Mar 2026 37.07 36.17 to 37.47 -3.56% 1.11 times
17 Tue Mar 2026 38.44 38.30 to 39.27 -0.36% 0.64 times
16 Mon Mar 2026 38.58 37.79 to 38.59 1.63% 0.72 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top